Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation

MLA

Wu Y, et al. “Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.” International Journal of COPD, vol. ume 15, Feb. 2020, pp. 397–407. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.3bbaf0cf50cd49ef9c035f9232e644f6&authtype=sso&custid=ns315887.

APA

Wu Y, Qin J, He J, Shen Y, Wang H, Li Y, Zeng Q, Dong J, An Y, Xiong S, Feng M, & Wen F. (2020). Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation. International Journal of COPD, ume 15, 397–407.

Chicago

Wu Y, Qin J, He J, Shen Y, Wang H, Li Y, Zeng Q, et al. 2020. “Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation.” International Journal of COPD ume 15 (February): 397–407. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.3bbaf0cf50cd49ef9c035f9232e644f6&authtype=sso&custid=ns315887.